Skip to search formSkip to main contentSkip to account menu

SK&F 105809

Known as: SKF-105809 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Imidazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
THE MIXED LIPOXYGENASE/CYCLOOXYGENASE INHIBITOR SK&F 105809 REDUCES CEREBRAL EDEMA AFTER CLOSED HEAD INJURY IN RAT
Closed head injury in rats induces edema formation, which is indicated by a decrease in cerebral specific gravity and an increase… 
1991
1991
Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
1991
1991
Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
1990
1990
Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
The effects of SK&F 105809, 6,7,-dihydro-2-[4(methylsulfinyl) phenyl]-3-(4-pyridyl) -5[H]-pyrrolo[1,2-a] imidazole, on eicosanoid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)